1 result(s) for Temodar
| PI Name | Protocol # | Title |
|---|---|---|
| Matthew Taylor | IRB00006867 | A Phase 1 Study of Oral Carboxyamidotriazole Orotate (CTO) Titrated as a Single Agent in Patients with Advanced or Metastatic Solid Tumors and Titrated in Combination Therapy with Temodar® in Patients with Glioblastom Multiforme |
You may qualify for additional trials within our Phase 1 Program